Compound | Tonic Block (HP −100 mV) IC50 | Use-Dependent Block | |||
---|---|---|---|---|---|
2 Hz | 10 Hz | ||||
IC50 | TB/UDB | IC50 | TB/UDB | ||
μM | μM | μM | |||
Toc | 523 ± 32 | 350 ± 11 | 1.5 | 248 ± 14 | 2.1 |
Benzyl-Toc | 5.4 ± 0.6a,b | 5.5 ± 0.6a,b | 0.98 | 2.9 ± 0.4a,b | 1.9 |
To5 | 168 ± 12c | 47 ± 4.8c | 3.6 | 23.2 ± 1.4c | 7.2 |
Benzyl-To5 | 29.7 ± 4.9a,b | 29.8 ± 6a,b | 0.99 | 15.8 ± 3a,b | 1.9 |
To9 | 94 ± 19c | 42.1 ± 9.6c | 2.2 | 38.2 ± 9c | 2.5 |
Benzyl-To9 | 3.9 ± 0.8a | 1.2 ± 0.2a | 3.3 | 0.50 ± 0.06a | 7.8 |
↵ a Significant difference of benzyl-analogs with respect to related nonbenzylated parent compounds (P < 0.05 for Benzyl-To5; P < 0.001 for Benzyl-Toc and Benzyl-To9).
↵ b Significant difference of benzyl-analogs with respect to Benzyl-To9 (P < 0.001).
↵ c Significant difference of proline-like analogs with respect to tocainide (P < 0.001).